Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bossi

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
European Journal of Pharmacology|June 8, 2011
Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patientsGiuseppe Derosa, Pietro Putignano, Antonio C Bossi, et al.
BMJ Open Diabetes Research & Care|August 4, 2016
PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatmentGiulia Buonaiuto, Valentina De Mori, Alessandra Braus, et al.
Current Diabetes Reviews|August 7, 2015
A Prospective Study for Introducing Insulin Pens and Safety Needles in a Hospital Setting. The SANITHY StudyAntonio C Bossi, Giovanni Veronesi, Carmine S Poerio, et al.
Journal of Endocrinological Investigation|November 12, 2022
Serum testosterone mirrors inflammation parameters in females hospitalized with COVID-19M F Birtolo, W Vena, A Pizzocaro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2001
Isolated presence of antibody to hepatitis B core antigen in injection drug users: do they need to be vaccinated?G Quaglio, F Lugoboni, S Vento, et al.
Diabetes Care|June 23, 2010
Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind clinical trialPiero Ruggenenti, Dario Cattaneo, Stefano Rota, et al.
Acta Diabetologica|March 13, 2018
Predictors of treatment response to liraglutide in type 2 diabetes in a real-world settingN Simioni, C Berra, M Boemi, et al.
Diabetes Research and Clinical Practice|February 27, 2022
Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial)Piero Ruggenenti, Monica Cortinovis, Matias Trillini, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 2, 2025
Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective StudyAlberto Piasentier, Maria Francesca Birtolo, Bianca Turci, et al.
Journal of Endocrinological Investigation|August 17, 2023
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitorsS Antonini, R Pedersini, M F Birtolo, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|June 8, 2011
Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patientsGiuseppe Derosa, Pietro Putignano, Antonio C Bossi, et al.
BMJ Open Diabetes Research & Care|August 4, 2016
PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatmentGiulia Buonaiuto, Valentina De Mori, Alessandra Braus, et al.
Current Diabetes Reviews|August 7, 2015
A Prospective Study for Introducing Insulin Pens and Safety Needles in a Hospital Setting. The SANITHY StudyAntonio C Bossi, Giovanni Veronesi, Carmine S Poerio, et al.
Journal of Endocrinological Investigation|November 12, 2022
Serum testosterone mirrors inflammation parameters in females hospitalized with COVID-19M F Birtolo, W Vena, A Pizzocaro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 24, 2001
Isolated presence of antibody to hepatitis B core antigen in injection drug users: do they need to be vaccinated?G Quaglio, F Lugoboni, S Vento, et al.
Diabetes Care|June 23, 2010
Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind clinical trialPiero Ruggenenti, Dario Cattaneo, Stefano Rota, et al.
Acta Diabetologica|March 13, 2018
Predictors of treatment response to liraglutide in type 2 diabetes in a real-world settingN Simioni, C Berra, M Boemi, et al.
Diabetes Research and Clinical Practice|February 27, 2022
Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial)Piero Ruggenenti, Monica Cortinovis, Matias Trillini, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 2, 2025
Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective StudyAlberto Piasentier, Maria Francesca Birtolo, Bianca Turci, et al.
Journal of Endocrinological Investigation|August 17, 2023
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitorsS Antonini, R Pedersini, M F Birtolo, et al.
Pageof 7